Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, Germany, have collaborated with scientists from Uppsala University in Sweden and Toronto University in Canada to map the infection pathways of aggressive Shigella bacteria in human intestinal organoids.
Organ-on-a-chip manufacturer Hesperos Inc. has announced a strategic collaboration with Psilera, a biopharmaceutical company developing therapies for difficult-to-treat neurological diseases such as frontotemporal dementia.
The European Partnership for Alternatives to Animal Testung (EPAA) has launched the EPAA’s Refinement Prize 2025 today.
Every year, the Controlled Release Society (CRS) honors outstanding individuals who have significantly advanced the field of drug release. This year, Prof. Claus-Michael Lehr was honored with the CRS Distinguished Service Award for his many years of commitment to the society and his significant contributions to pharmaceutical science.
InSphero, a global leader in 3D in vitro technology for drug safety and efficacy testing, is partnering with PCRM to offer the 2025 Human Advanced In Vitro Model Initiative (HUMAIN) Award.
In a campaign launched in April this year, the European Animal Research Association (EARA) justifies the use of dogs in biomedical research and development and argues that this should continue.(1) European animal rights organizations, which are united in the European Coalition to End Animal Experiments (ECEAE), strongly criticize this and refute the arguments.(2)
There is an S1 laboratory in the building of the Academy for Animal Welfare Academy of the German Animal Welfare Federation (DTSchB) in Neubiberg near Munich. The laboratory is to be rented out for use for animal-free (research) projects.
Scientists at the Vienna University of Technology (TU Wien) together with Keio University in Japan have developed a new method for creating blood vessels in tiny organ models on a chip - using ultrashort laser pulses.
On the platform of the Free Association of Student Unions (fzs), students are calling for new animal-free methods to be taught in all relevant study programs right from the start.
In a study, a team of scientists has developed an in vitro model to investigate processes in type 1 diabetes. The model investigates the impairment of human alpha cells by pro-inflammatory cytokines and possible therapeutically effective substances.